Therapeutic efficacy of vitamin e δ-tocotrienol in collagen-induced rat model of arthritis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Haleagrahara, Nagaraja ^a   Swaminathan, Mirashini ^b   Chakravarthi, Srikumar ^c   Radhakrishnan, Ammu ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^c PERDANA UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; COLLAGEN TYPE 2; DELTA TOCOTRIENOL; FREUND ADJUVANT; GLUCOSAMINE; UNCLASSIFIED DRUG; COLLAGEN; TOCOTRIENOL, DELTA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; NONHUMAN; PAW EDEMA; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; ANALOGS AND DERIVATIVES; ANIMAL; ARTHRITIS, EXPERIMENTAL; BODY WEIGHT; CELL CULTURE; CELL PROLIFERATION; CYTOCHEMISTRY; CYTOLOGY; DRUG EFFECTS; HINDLIMB; PATHOLOGY; SPLEEN;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BODY WEIGHT; C-REACTIVE PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; FEMALE; HINDLIMB; HISTOCYTOCHEMISTRY; RATS; SPLEEN; VITAMIN E;

EID: 84904699321     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/539540     Document Type: Article

References (32)

1. Toh B. H., Sengupta S., Ang A. H., White J. C., Lau K. S., Pattern of rheumatoid arthritis in West Malaysia. Annals of the Rheumatic Diseases 1973 32 2 151 156
2. Smith C. A., Arnett F. C., Epidemiologic aspects of rheumatoid arthritis. Current immunogenetic approach. Clinical Orthopaedics and Related Research 1991 265 23 35
3. Chaiamnuay S., Bridges S. L. Jr., The role of B cells and autoantibodies in rheumatoid arthritis. Pathophysiology 2005 12 3 203 216 10.1016/j.pathophys. 2005.07.007 (Pubitemid 41375643)
4. Romas E., Gillespie M. T., Martin T. J., Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002 30 2 340 346 (Pubitemid 34154863)
5. Kalra E. K., Nutraceutical-definition and introduction. AAPS PharmSciTech 2003 5 3, article E25
6. Lockwood G. B., The quality of commercially available nutraceutical supplements and food sources. The Journal of Pharmacy and Pharmacology 2011 63 1 3 10
7. Sundram K., Sambanthamurthi R., Tan Y. A., Palm fruit chemistry and nutrition. Asia Pacific Journal of Clinical Nutrition 2003 12 3 355 362 (Pubitemid 38880724)
8. Kamal-Eldin A., Appelqvist L. A., The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996 31 7 671 701 10.1007/BF02522884 (Pubitemid 26240763)
9. Ramdas P., Rajihuzzaman M., Veerasenan S. D., Selvaduray K. R., Nesaretnam K., Radhakrishnan A. K., Tocotrienol-treated MCF-7 human breast cancer cells show down-regulation of API5 and up-regulation of MIG6 genes. Cancer Genomics Proteomics 2011 8 1 19 31
10. Kelsey N. A., Wilkins H. M., Linseman D. A., Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010 15 11 7792 7814 10.3390/molecules15117792
11. Vierboom M. P., Breedveld E., Kondova I., 't Hart B. A., Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis. Arthritis Research & Therapy 2010 12 5, article R200
12. Portanova J. P., Zhang Y., Anderson G. D., Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. The Journal of Experimental Medicine 1996 184 3 883 891 10.1084/jem.184.3.883
13. Steffen C., Timpl R., Antigenicity of collagen and its application in the serological investigation of rheumatoid arthritis sera. International Archives of Allergy and Applied Immunology 1963 22 333 349
14. Asquith D. L., Miller A. M., McInnes I. B., Liew F. Y., Animal models of rheumatoid arthritis. European Journal of Immunology 2009 39 8 2040 2044
15. Brand D. D., Kang A. H., Rosloniec E. F., Immunopathogenesis of collagen arthritis. Springer Seminars in Immunopathology 2003 25 1 3 18 10.1007/s00281-003-0127-1 (Pubitemid 37000035)
16. Ueno M., Imaizumi K., Sugita T., Takata I., Takeshita M., Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis. International Journal of Immunopharmacology 1995 17 7 597 603
17. Ahn K. S., Sethi G., Krishnan K., Aggarwal B. B., Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. The Journal of Biological Chemistry 2007 282 1 809 820 (Pubitemid 47076658)
18. Qureshi A. A., Reis J. C., Papasian C. J., Morrison D. C., Qureshi N., Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice. Lipids in Health and Disease 2010 9 1 143 10.1186/1476-511X-9-143
19. Qureshi A. A., Reis J. C., Qureshi N., Papasian C. J., Morrison D. C., Schaefer D. M., δ-tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids in Health and Disease 2011 10, article 39
20. Chen C. W., Cheng H. H., A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. The Journal of Nutrition 2006 136 6 1472 1476
21. Palozza P., Verdecchia S., Avanzi L., Vertuani S., Serini S., Iannone A., Manfredini S., Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells. Molecular and Cellular Biochemistry 2006 287 1-2 21 32 10.1007/s11010-005-9020- 7 (Pubitemid 44057389)
22. Yam M. L., Abdul Hafid S. R., Cheng H. M., Nesaretnam K., Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids 2009 44 9 787 797 10.1007/s11745-009-3326-2
23. Akama H., Saito S., Glucosamine and chondroitin for osteoarthritis. Arthritis & Rheumatology 2001 45 1 107
24. Kannan K., Ortmann R. A., Kimpel D., Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005 12 3 167 181 (Pubitemid 41375640)
25. Nakae S., Nambu A., Sudo K., Iwakura Y., Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. Journal of Immunology 2003 171 11 6173 6177 (Pubitemid 37467240)
26. Tomita T., Kakiuchi Y., Tsao P. S., THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis. Arthritis Research & Therapy 2006 8 1, article R7
27. Ostberg T., Wahamaa H., Palmblad K., Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis. Arthritis Research & Therapy 2008 10 1 R1
28. Andersson U., Tracey K. J., HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheumatic Diseases Clinics of North America 2004 30 3 627 637 (Pubitemid 38917005)
29. Skapenko A., Leipe J., Lipsky P. E., Schulze-Koops H., The role of the T cell in autoimmune inflammation. Arthritis Research & Therapy 2005 7 supplement 2 S4 S14 (Pubitemid 40936615)
30. Poole C. D., Conway P., Reynolds A., Currie C. J., The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study. BMC Musculoskeletal Disorders 2008 9 146
31. Larsson E., Erlandsson Harris H., Lorentzen J. C., Larsson A., Mansson B., Klareskog L., Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Rheumatology 2002 41 9 996 1000
32. Brull D. J., Serrano N., Zito F., Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 11 2063 2069 (Pubitemid 37433201)